Home > Insider Trading > Filing (0001104659-20-012076)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1609550	Inspire Medical Systems Inc.	INSP	Surgical & Medical Instruments & Apparatus (3841)	261377674

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1737127	Randy Ban	C/O Inspire Medical Systems, Inc. 5500 Wayzata Blvd., Suite 1600 Golden Valley MN 55416	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2019-04-15	200	$0.00	700	No	5	G	Direct
Common Stock	Disposition	2019-04-23	167	$0.00	533	No	5	G	Direct
Common Stock	Disposition	2019-04-23	166	$0.00	367	No	5	G	Direct
Common Stock	Acquisiton	2019-04-23	167	$0.00	167	No	5	G	Indirect	By son
Common Stock	Acquisiton	2019-04-23	166	$0.00	166	No	5	G	Indirect	By daughter
Common Stock	Disposition	2019-04-24	200	$0.00	167	No	5	G	Direct
Common Stock	Disposition	2019-04-29	167	$0.00	0	No	5	G	Direct
Common Stock	Acquisiton	2020-02-04	10,000	$1.14	10,000	No	4	M	Direct
Common Stock	Disposition	2020-02-04	6,797	$75.63	3,203	No	4	S	Direct
Common Stock	Disposition	2020-02-04	2,558	$77.29	645	No	4	S	Direct
Common Stock	Disposition	2020-02-04	645	$78.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Direct
No	5	G	Direct
No	5	G	Direct
No	5	G	Indirect	By son
No	5	G	Indirect	By daughter
No	5	G	Direct
No	5	G	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-04	10,000	$0.00	10,000	$1.14

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
65,187		2023-09-11	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.29 to $76.23. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.82 to $77.77. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.82 to $78.17. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option is fully vested and exercisable.